Inventor · disambiguated record
Marschall S. Runge
Also filed as: RUNGE MARSCHALL · RUNGE MARSCHALL S · RUNGE MARSCHALL STEVENS
10 granted patents·1 pending application·371 citations·filing 1992–2011
91Inventor score
Top patents by PatentIndex Score
11 records- 0193US5364771AHybrid human/porcine factor VIIIUNIV EMORY·Filed 1992·Granted Nov 15, 1994·129 cites·19 claims
- 0287US5744446AHybrid human/animal factor VIIIUNIV EMORY·Filed 1995·Granted Apr 28, 1998·84 cites·20 claims
- 0381US5663060AHybrid human/animal factor VIIIUNIV EMORY·Filed 1994·Granted Sep 2, 1997·52 cites·23 claims
- 0475US5583209AHybrid human/porcine factor VIIIUNIV EMORY·Filed 1994·Granted Dec 10, 1996·31 cites·10 claims
- 0569US7267946B2Mitochondrial DNA damage as a predictor of coronary atherosclerotic heart diseaseRES DEV FOUNDATION·Filed 2001·Granted Sep 11, 2007·2 cites·13 claims
- 0665US5888974AHybrid human/animal factor VIIIUNIV EMORY·Filed 1995·Granted Mar 30, 1999·29 cites·2 claims
- 0755US5811265AHybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and useGEN HOSPITAL CORP·Filed 1993·Granted Sep 22, 1998·19 cites·6 claims
- 0847US5443827AFibrin-targeted inhibitors of thrombinHARVARD COLLEGE·Filed 1993·Granted Aug 22, 1995·9 cites·14 claims
- 0945US5609869AHybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and useGEN HOSPITAL CORP·Filed 1995·Granted Mar 11, 1997·9 cites·5 claims
- 1045US2013171163A1Inhibition of LAR Phosphatase to Enhance Therapeutic AngiogenesisRUNGE MARSCHALL·Filed 2011·Application pending·0 cites
- 1141US6322974B1Mitochondrial DNA damage as a predictor of coronary atherosclerotic heart diseaseRES DEV FOUNDATION·Filed 1999·Granted Nov 27, 2001·7 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Marschall S. Runge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →